676
Views
13
CrossRef citations to date
0
Altmetric
Drug Evaluations

Eltrombopag in patients with chronic liver disease

, MD PhD FACG FRSM &
Pages 669-678 | Published online: 04 Mar 2013

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Tamer A Elbedewy, Mohamed A Elsebaey, Samah A Elshweikh, Heba Elashry & Sherief Abd-Elsalam. (2019) Predictors for eltrombopag response in patients with hepatitis C virus-associated thrombocytopenia. Therapeutics and Clinical Risk Management 15, pages 269-274.
Read now
Bibek Aryal, Munekazu Yamakuchi, Toshiaki Shimizu, Jun Kadono, Akira Furoi, Kentaro Gejima, Teruo Komokata, Teruto Hashiguchi & Yutaka Imoto. (2018) Therapeutic implication of platelets in liver regeneration –hopes and hues. Expert Review of Gastroenterology & Hepatology 12:12, pages 1219-1228.
Read now

Articles from other publishers (11)

Romeo-Gabriel Mihăilă. (2017) A Look at Platelet Count in Chronic Hepatitis C Infection. EMJ Hepatology, pages 97-103.
Crossref
. 2016. Meyler's Side Effects of Drugs. Meyler's Side Effects of Drugs 925 928 .
Raoel Maan, Adriaan J. van der Meer, Bettina E. Hansen, Jordan J. Feld, Heiner Wedemeyer, Jean-François Dufour, Hooman F. Zangneh, Frank Lammert, Michael P. Manns, Stefan Zeuzem, Harry L.A. Janssen, Robert J. de Knegt & Bart J. Veldt. (2014) Effect of thrombocytopenia on treatment tolerability and outcome in patients with chronic HCV infection and advanced hepatic fibrosis. Journal of Hepatology 61:3, pages 482-491.
Crossref
Aviva Leber & Jordan J. Feld. (2014) Does Eltrombopag Really ENABLE SVR?. Gastroenterology 146:2, pages 339-342.
Crossref
Nezam H. Afdhal, Geoffrey M. Dusheiko, Edoardo G. Giannini, Pei–Jer Chen, Kwang–Hyub Han, Aftab Mohsin, Maribel Rodriguez–Torres, Sorin Rugina, Igor Bakulin, Eric Lawitz, Mitchell L. Shiffman, Ghias–Un–Nabi Tayyab, Fred Poordad, Yasser Mostafa Kamel, Andres Brainsky, James Geib, Sandra Y. Vasey, Rita Patwardhan, Fiona M. Campbell & Dickens Theodore. (2014) Eltrombopag Increases Platelet Numbers in Thrombocytopenic Patients With HCV Infection and Cirrhosis, Allowing for Effective Antiviral Therapy. Gastroenterology 146:2, pages 442-452.e1.
Crossref
Vishal Sharma. (2014) Use of eltrombopag in thrombocytopenia of liver disease. World Journal of Pharmacology 3:4, pages 186.
Crossref
Romeo-Gabriel Mihăilă. (2014) Eltrombopag in chronic hepatitis C. World Journal of Gastroenterology 20:35, pages 12517.
Crossref
Gregory T. Everson & Asmeen Bhatt. (2013) Treatment of Hepatitis C in the Patient with Decompensated Cirrhosis. Current Hepatitis Reports 12:4, pages 236-245.
Crossref
Asmeen Bhatt & y Gregory T. Everson. (2013) Virus de la hepatitis C: Terapia antiviral en pacientes en la lista de espera. Clinical Liver Disease 2:S5, pages 73-77.
Crossref
Asmeen Bhatt & Gregory T. Everson. (2013) Hepatitis C virus: Antiviral therapy in wait-listed patients. Clinical Liver Disease 2:4, pages 173-176.
Crossref
Kazuhiro Takahashi. (2013) Platelet therapy: A novel strategy for liver regeneration, anti-fibrosis, and anti-apoptosis. World Journal of Surgical Procedures 3:3, pages 29.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.